tradingkey.logo
tradingkey.logo
Search

Palvella Therapeutics Strengthens Leadership With Appointment Of Accomplished Scientist And Biopharmaceutical Executive David W. Osborne, Ph.D. As Chief Innovation Officer

ReutersSep 3, 2025 12:31 PM
facebooktwitterlinkedin

- Arcutis Biotherapeutics Inc ARQT.O:

  • PALVELLA THERAPEUTICS STRENGTHENS LEADERSHIP WITH APPOINTMENT OF ACCOMPLISHED SCIENTIST AND BIOPHARMACEUTICAL EXECUTIVE DAVID W. OSBORNE, PH.D. AS CHIEF INNOVATION OFFICER

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI